0
Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council and in particular Article 27(1) thereof, whereas:(1) In order to protect public health, pharmacologically active substances, on the basis of the scientific assessment of the safety of those substances, were classified in four Annexes to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin.
Annex I contained substances for which a maximum residue limit was established, Annex II contained substances for which it was not necessary to establish a maximum residue limit, Annex III contained substances for which a provisional maximum residue limit was established and Annex IV contained substances for which a maximum residue limit could not be established because residues of those substances, at whatever limit, constitute a hazard to human health.
For reasons of simplification, it is necessary to incorporate those pharmacologically active substances and their classification regarding maximum residue limits in a Commission Regulation. As this classification follows the classification system foreseen in Regulation (EC) No 470/2009, the classification should also be taken account of with regard to the possibility to administer those pharmacologically active substances to food-producing animals.
Existing information on the therapeutical classification of pharmacologically active substances contained in the Annexes to Regulation (EEC) No 2377/90 should be incorporated into a column on the therapeutical classification of substances.
For reasons of ease of use, all pharmacologically active substances should be listed in one Annex in alphabetical order. For reasons of clarity, two separate tables should be established: one for allowed substances, listed in Annexes I, II and III of Regulation (EEC) No 2377/90, and one for prohibited substances, listed on Annex IV to that Regulation.
Provisional maximum residue limits for pharmacologically active substances, laid down in Annex III to Regulation (EEC) No 2377/90 for which the period of application has ended, should not be incorporated into this Regulation.
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:015:0001:0072:EN:PDF
